It’s inspiring to support founders, executives and investors in realizing successful outcomes from the effort, sacrifices and capital investments they put into building high-quality organizations.
Brian provides healthcare companies with strategic advice and perspective regarding their businesses, including company positioning, market trends, financing options, strategic alternatives, valuation and timing. He has more than 20 years of mergers and acquisitions (M&A) and investment banking experience, working in partnership with management teams, boards of directors, venture capital and growth equity firms. Brian’s M&A advisory experience includes successful engagements for both private and public companies, U.S. domestic and cross-border transactions, reverse mergers, divestitures and special situation assignments across all segments of healthcare with a primary focus on life sciences companies.
Brian understands the value drivers for healthcare companies and how to position these companies to prospective buyers or investors. Lincoln’s fully-integrated global footprint allows Brian to provide his clients with greater access to a broad set of strategic buyers and investors, helping them orchestrate a robust and international process to maximize shareholder returns.
Prior to joining Lincoln, Brian was a managing director in JMP Securities’ healthcare investment banking group and a key contributor in establishing the firm’s healthcare practice. Previously, Brian worked in the healthcare investment banking group at RBC Capital Markets, where he focused on life sciences clients.
Brian earned a Bachelor of Science from Northern Arizona University.
Lincoln International is pleased to announce the sale of substantially all of the operating assets of Valeritas Holdings, Inc. (NASDAQ:VLRX) pursuant to Section 363 of the U.S. Bankruptcy Code to Zealand Pharma A/S (NASDAQ:ZEAL)
Lincoln International advised Verogen Inc., a portfolio company of Telegraph Hill Partners, on the acquisition of GEDmatch Incorporated
Lincoln International is pleased to announce the sale of Diversigen, a portfolio company of Baylor College of Medicine, to OraSure Technologies
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical
Perspectives by Brian Bock
Outlook of COVID-19 Impact on Global Medtech M&A / Business Development
The Current Environment – Commentary COVID-19 is delivering a true one-two punch to the economy. The first punch stunned global markets with a complete shut-down of activity, but coming out of March […]
U.S.-China Tensions, Tariffs and Tightening Regulations
Tension and tariffs drives Chinese M&A activity to markets outside the U.S. Mounting tension between Washington, D.C. and Beijing are top of mind in the dealmaking climate. As tariffs continue to dominate […]
Q&A: The Evolution of Medtech in a Globalizing Industry
View original post from Pitchbook on May 29, 2019 here. […]